NeoGenomics, Inc. (NEO)

NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.26 billion as of November 3, 2025. Its market cap has decreased by -28.72% in one year.

• Market Cap: 1.26B
• Enterprise Value: 1.51B
• 1-Year Change: -28.72%
• Ranking: #2342
• Category: Small-Cap
• Stock Price: $9.78

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.26B, an increase of 15,891.77%. That is a compound annual growth rate of 26.43%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	1.26B	-40.24%
Dec 31, 2024	2.12B	2.57%
Dec 29, 2023	2.06B	76.73%
Dec 30, 2022	1.17B	-72.22%
Dec 31, 2021	4.20B	-29.72%
Dec 31, 2020	5.98B	95.74%
Dec 31, 2019	3.05B	160.37%
Dec 31, 2018	1.17B	64.64%
Dec 29, 2017	712.40M	5.87%
Dec 30, 2016	672.90M	41.66%
Dec 31, 2015	475.00M	89.92%
Dec 31, 2014	250.10M	41.06%
Dec 31, 2013	177.30M	57.88%
Dec 31, 2012	112.30M	85.62%
Dec 30, 2011	60.50M	24.49%
Dec 31, 2010	48.60M	-12.90%
Dec 31, 2009	55.80M	189.12%
Dec 31, 2008	19.30M	-43.07%
Dec 31, 2007	33.90M	-16.30%
Dec 29, 2006	40.50M	841.86%
Dec 30, 2005	4.30M	-20.37%
Dec 31, 2004	5.40M	-31.65%
Mar 16, 2004	7.90M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	772.59B
Johnson & Johnson	455.04B
AbbVie	385.18B
UnitedHealth Group	309.40B
AstraZeneca	253.98B
Novartis AG	237.13B
Novo Nordisk	216.87B
Abbott Laboratories	214.96B